Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease.
This article describes the use of nebulized morphine in the management of dyspnea in two patients with end-stage chronic lung disease, and two patients with end-stage heart failure. All four patients had relief of breathlessness. Arterial blood gas results and vital signs were monitored pre- and postnebulized morphine in two of the patients and demonstrated little change. Nebulized morphine appears to be well tolerated in this patient population.
Farncombe
M
M
Palliative Care Service, Ottawa Civic Hospital, Ontario, Canada.
Chater
S
S
D000368:Aged; D002303:Cardiac Output, Low / Q000150:complications*; D002908:Chronic Disease; D004417:Dyspnea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications*; D008297:Male; D009020:Morphine / Q000008:administration & dosage*; D009330:Nebulizers and Vaporizers
D009020:Morphine